Medication info
Glycue Tablet (Glimepiride)

Glycue Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Joah Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 200 tablets/bottle
Approval status
Active

MFDS item code 200512325 · Notified 2005.01.05 · Insurance code 644602570

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this drug orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this drug There is no exact dose equivalence between this drug and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this drug, it is advisable to follow the instructions given under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Take into account the potency and duration of action of the previous medication. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this drug, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer this drug at 8 mg once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant use of this drug and metformin, and this risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Joah Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control disorder in patients with type 2 diabetes
View approved original text

This medication aids in improving blood sugar control in patients with type 2 diabetes by supplementing dietary and exercise therapy. It can be administered alone, and in cases where blood sugar control is insufficient, it can be used in combination with oral hypoglycemic agents or insulin. Additionally, in cases where the effect of sulfonylureas or metformin monotherapy is inadequate, it can be administered together with metformin. This medication helps to effectively control blood sugar levels and assist in diabetes management.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Administer this drug orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this drug There is no exact dose equivalence between this drug and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this drug, it is advisable to follow the instructions given under Initial dose. That is, initiate treatment at 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Take into account the potency and duration of action of the previous medication. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this drug, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer this drug at 8 mg once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant use of this drug and metformin, and this risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis. It is also safe to avoid administration in cases of allergy to this medication or its components. There is no previous experience with this medication in patients with severe liver or kidney dysfunction, so it is recommended to switch to insulin therapy. Pregnant women or women who may become pregnant, as well as nursing mothers, should not be administered this medication. It is safer for patients with severe infections or those undergoing surgery or with severe trauma to receive insulin therapy. Caution is necessary for patients with gastrointestinal disturbances such as diarrhea or vomiting, as improper food absorption may pose a risk of hypoglycemia. During the first week of administration, the risk of hypoglycemia is high, so blood sugar levels should be monitored closely. Special caution is required for the elderly, those in poor nutritional status or skipping meals, and those consuming alcohol. Patients who have an imbalance in muscle activity and carbohydrate intake, or those with compromised kidney and liver function, may also respond more sensitively to this medication. Furthermore, patients with other endocrine diseases or those taking concurrent medications should be informed of the increased risk of hypoglycemia. This medication lowers blood sugar levels, which may lead to hypoglycemia. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and in severe cases, unconsciousness. It is important to consume sugary foods quickly to raise blood sugar levels if hypoglycemia occurs. Moreover, various side effects such as visual disturbances, gastrointestinal disorders, liver function abnormalities, blood abnormalities, and allergic reactions may occur, so if abnormalities arise, immediate consultation with a doctor is necessary. While taking this medication, regular meals, exercise, and weight management should be accompanied, and patients and their families should be thoroughly informed about the risks and symptoms of hypoglycemia, as well as treatment methods. It is advisable to always carry sugary foods in case of hypoglycemia. In situations of stress, surgery, infection, etc., that make blood sugar control challenging, temporary switching to insulin therapy may also be considered. When taking other medications, it may affect blood sugar control, so all medications being taken should be reported to a doctor or pharmacist. Caution is particularly necessary when taking medications that affect the enzymes that metabolize this medication in the liver. During pregnancy or breastfeeding, this medication should not be used as it could harm the fetus or newborn, and if necessary, switching to insulin therapy or discontinuing breastfeeding should be considered. This medication is not recommended for use in children under 18 years of age as safety and efficacy have not been established. For the elderly, caution should be exercised in dosage adjustment as renal function may be impaired. In case of overdose, severe hypoglycemia may occur, requiring immediate emergency measures. Treatment such as inducing vomiting, gastric lavage, or intravenous glucose may be necessary, so preparedness for emergencies is essential. Finally, it is important to store this medication out of reach of children and keep it in its original container, and to take it exactly as directed by a physician.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disturbances
  • anxiety
  • aggression
Show 68 more
  • decreased concentration
  • decreased agility or activity
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual disturbances
  • tremor
  • incomplete paralysis
  • sensory disturbances
  • dizziness
  • weakness
  • loss of self-control
  • transient mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorder
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • itching
  • urticaria
  • rash
  • dyspnea
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photosensitivity reactions in the skin
  • decreased serum sodium levels
  • taste disorders
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial swelling
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to keep out air and moisture. Additionally, it is best stored at room temperature between 1°C and 30°C. Avoid storing it in places that are too hot or too cold for safe storage.

Appearance and packaging

Appearance

Green rectangular tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.